US Stock MarketDetailed Quotes

ALTR Altair Engineering

Watchlist

87.560
-4.300-4.68%

Close Jul 24 16:00 ET

87.560
0.0000.00%

Post 16:00 ET

7.27BMarket Cap796.00P/E (TTM)

Altair Engineering Stock Forum

Moomoo AI

Mar 21 11:24

Altair Engineering's ROCE trend is concerning, having declined over the past five years. Despite this, the stock has yielded a 124% return to long-term shareholders, reflecting market optimism. However, if these trends continue, it may not be a multi-bagger in the future.

There Are Reasons To Feel Uneasy About Altair Engineering's (NASDAQ:ALTR) Returns On Capital

Moomoo AI

Feb 29 08:25

Altair Engineering's high P/S ratio may not be justified due to weak revenue forecasts. This could pose a risk to shareholders and potential investors as it may negatively impact the share price.

Unpleasant Surprises Could Be In Store For Altair Engineering Inc.'s (NASDAQ:ALTR) Shares

Moomoo AI

Feb 8 04:34

Altair Engineering's revenue growth, reflected in its rising share price, is the market's focus due to lack of profits. Recent positive sentiment suggests potential business momentum.

Investors Bid Altair Engineering (NASDAQ:ALTR) up US$364m Despite Increasing Losses YoY, Taking Five-year CAGR to 21%

Meticulous Trader

Jan 19 14:12

$Altair Engineering(ALTR.US)$ low Reward/Risk ratio not interested here. hit hard several stonks panic buying not considering R/R ratio . No more emotions attached to fear of missing plays in market. always careful 👍🏻

Moomoo AI

Jan 12 13:59

The recent selling of shares by insiders at Altair Engineering, without any recorded purchases, may raise concerns among shareholders. Despite the high level of insider ownership, the lack of buying activity does not inspire confidence in the company's prospects.

Altair Engineering Insiders Sold US$3.3m Of Shares Suggesting Hesitancy

Moomoo AI

Nov 11, 2023 07:44

Investors: monitor for potential price drop due to current overvaluation. Current timing may not be ideal for entry due to surpassing of true value. However, optimistic outlook suggests looking into other factors for next price drop.

Should You Investigate Altair Engineering Inc. (NASDAQ:ALTR) At US$70.03?

Analysts Notebook

Jul 27, 2022 06:42

ColumnsTop upgrades and downgrades on 7/27: MCD, SHOP, SLB, LOGI and more

Upgrades
• $Carvana(CVNA.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $Newmont(NEM.US)$ : Canaccord Upgrades to Buy from Hold - PT $66 (from $60)
• $NiSource(NI.US)$ : Edward Jones Upgrades to Buy from Hold
• $Schlumberger(SLB.US)$ : Benchmark Upgrades to Buy from Hold - PT $55
Downgrades
• $Agilysys(AGYS.US)$ : Craig-Hallum Downgrades to Hold from Buy
• $Cleveland-Cliffs(CLF.US)$ : GLJ Research Downgrades t...

Moomoo Breakfast US

Jun 27, 2022 07:09

ColumnsToday's pre-market stock movers: BNTX, JBLU, DWAC, SAVE and more

Gainers:
• $Axsome Therapeutics(AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics(CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...

Analysts Notebook

Jun 27, 2022 07:02

ColumnsTop upgrades and downgrades on 6/27: ETSY, CHWY, BBBY, GTLB and more

Upgrades
• $AutoZone(AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...

Analysts Notebook

Nov 5, 2021 10:17

ColumnsTop upgrades and downgrades on 11/05

Friday, November 5, 2021
By Mia
$Redbox Entertainment(RDBX.US)$ $Altair Engineering(ALTR.US)$ $BCE Inc(BCE.US)$ $Skyworks Solutions(SWKS.US)$ $Regeneron Pharmaceuticals(REGN.US)$

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall